Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aarti Drugs Limited Call Transcript 2023

Apr 27, 2023

62194_rns_2023-04-27_f7152990-c4c9-46f9-8a99-7763daa030ca.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [512 x 106] intentionally omitted <==

Ref: ADL/SE/2023-24/09 April 27, 2023

To, To, Listing/ Compliance Department Listing/ Compliance Department BSE Limited National Stock Exchange of India Phiroze Jeejeebhoy Towers, Limited, Dalal Street, “Exchange Plaza”, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400051 NSE SYMBOL: AARTIDRUGS BSE CODE – 524348

Dear Sir/Madam,

Ref : Regulation 30(6) of SEBI (LODR) Regulations, 2015 Sub: Intimation of Conference Call

This is to inform you that Quarterly Conference Call for the Investors and Analysts has been scheduled on Tuesday, May 02, 2023 at 10:00 A.M. IST to discuss the Company’s financial performance for the Quarter and year ended March 31, 2023. Please find attached herewith invitation for the same.

Kindly take the same on record.

Thanking you,

Yours faithfully,

FOR AARTI DRUGS LIMITED

RUSHIKESH VIVEK DEOLE Digitally signed by RUSHIKESH VIVEK DEOLE DN: c=IN, o=PERSONAL, title=5599, pseudonym=52288d43536c4230831c2e75cd4b8c59, 2.5.4.20=073813c4edff683f8b6ec3cb4e69ca6d8d4f7258a44f635abc18581eaa522821, postalCode=421301, st=Maharashtra, serialNumber=9b60f64457feab7f455d17463ebe710861bf01b575f6fc0484483273dabfc17f, cn=RUSHIKESH VIVEK DEOLE Date: 2023.04.27 20:24:34 +05'30'

RUSHIKESH DEOLE COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M.No.: A54527

==> picture [468 x 29] intentionally omitted <==

==> picture [117 x 54] intentionally omitted <==

Aarti Drugs Limited

Cordially invites you to

Conference Call

To discuss the financial performance for the Quarter and Financial Year ended 31[st] March, 2023

Day/Date : Tuesday, 02[nd] May, 2023 Time : 10:00 AM, IST

Diamond Pass : Please Click here to express join the Call

Primary Number: +91 226280 1309
+91 22 7115 8210
Toll Free Number: Hongkong– 800964448
Singapore– 8001012045
UK– 08081011573
US– 18667462133

Participants:

Mr. Harshit Savla – Jt. Managing Director

Mr. Harit Shah – Wholetime Director

Mr. Adhish Patil – Chief Finance Officer

Mr. Vishwa Savla – Managing Director, Pinnacle Life Science Private Limited

We look forward to your participation

RSVP

Jigar Kavaiya / Chinmay Madgulkar, Strategic Growth Advisors Pvt. Ltd., Contact: +91 99206 02034/ 98600 88296